News

Scientists have discovered a method to induce human endothelial cells from a small biopsy sample to multiply in the laboratory, producing more than enough cells to replace damaged blood vessels or nourish organs for... Read more

Video of Research at Risk: Rooting out treatment-resistant prostate cancer Advances in prostate cancer early detection and treatment have improved outcomes in men diagnosed with the disease . Yet doctors and scientists have... Read more

Triple negative breast cancer (TNBC) is one of the most aggressive and hardest to treat breast cancers, but a new study led by Weill Cornell Medicine suggests a way to stop it from spreading. Researchers have discovered that... Read more

Weill Cornell Medicine faculty member Dr. Anna Nam and postdoctoral fellow Dr. Maria Cecilia Lira have been chosen to join the 2025 class of Pew scholars and fellows. Dr. Nam, an assistant professor of pathology and... Read more

The Sandra and Edward Meyer Cancer Center (MCC) of Weill Cornell Medicine and NewYork - Presbyterian Hospital has appointed Laura Pinheiro, PhD, MPH to join Erica Phillips, MD in co-leading the Center’s Office of Community... Read more

Weill Cornell Medicine researchers have discovered that PD-1—a molecule best known for putting the brakes on immune cells—also plays a critical role in helping T cells become long-term immune defenders in the skin. Early... Read more

Experts in newest treatment option for cancer, neurological disorders unite to speed progress, expand access Consortium members will share resources, collaborate on clinical trials Statewide experts look to expand benefits... Read more

Video of Research at Risk: Stopping metastatic cancer Metastasis. It’s the word cancer patients dread most – and the scan with ominous black spots showing the disease has spread. For too many people, metastatic cancer is... Read more

A large prospective, randomized clinical trial in patients with advanced breast cancer has found that the use of liquid biopsy blood tests for early detection of a treatment-resistance mutation, followed by a switch to a new... Read more